Predictive value of weight loss on mortality of HIV-positive mothers in a prolonged breastfeeding setting

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1141-8. doi: 10.1089/AID.2010.0293. Epub 2011 Feb 16.

Abstract

HIV-positive lactating women may be at high risk of weight loss due to increased caloric requirements and postpartum physiological weight loss. Ten percent weight loss is associated with a higher risk of mortality in HIV-positive patients and this alone is a criterion for highly active antiretroviral therapy (HAART) initiation where CD4 counts are not available. However, no study has investigated this association in lactating postpartum women. We investigated whether 10% weight loss predicts death in postpartum HIV-positive women. A total of 9207 HIV-negative and 4495 HIV-positive mothers were recruited at delivery. Women were weighed at 6 weeks, 3 months, and every 3 months thereafter for up to 24 months postpartum and data on mortality up to 2 years were collected. The median duration of breastfeeding was longer than 18 months. Among HIV-positive women, the independent predictors of ≥10% weight loss were CD4 cell count, body mass index, and household income. Mortality was up to 7.12 (95% CI 3.47-14.61) times higher in HIV-positive women with ≥10% weight loss than those without weight loss. Ten percent weight loss in postpartum lactating HIV-positive women was significantly predictive of death. Our findings suggest that 10% weight loss is an appropriate criterion for HAART initiation among postpartum breastfeeding women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active / methods
  • Body Mass Index
  • Breast Feeding / adverse effects*
  • CD4 Lymphocyte Count
  • Female
  • HIV Seropositivity / drug therapy
  • HIV Seropositivity / mortality*
  • Humans
  • Income
  • Infant, Newborn
  • Postpartum Period
  • Predictive Value of Tests
  • Risk Factors
  • Time Factors
  • Weight Loss*
  • Young Adult